USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR … – P&T Community
|
USPTO rejects new reexamination request against Celyad's US Patent for Production of Allogeneic TCR-Deficient CAR …
P&T Community “This is the fourth time that our US Patent for Production of Allogeneic TCR-Deficient CAR–T cells is challenged and each time, the USPTO has been favorable to Celyad. This patent is key for the players that are developing in the US allogeneic CAR–T … |
